Notable Analyst Rating Changes 09/06: (AKS) (ATVI) (GOLD) Upgraded; (NOK) (CLF) (OCZ) Downgraded
Get Alerts AKS Hot Sheet
Join SI Premium – FREE
UPGRADES
Longbow Research lifts AK Steel (NYSE: AKS) from Neutral to Buy.
Piper Jaffray boosts Activision Blizzard (Nasdaq: ATVI) from Neutral to Overweight, moving its price target from $13 to $14.
JPMorgan upgrades Randgold Resources Ltd. (Nasdaq: GOLD) from Neutral to Overweight.
Janney Montgomery Scott raises Wright Express (NYSE: WXS) from Neutral to Buy, while moving its price target from $61 up to $75.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Nokia (NYSE: NOK) downgraded by two today:
NEW COVERAGE
Credit Suisse initiates Arena Pharma (Nasdaq: ARNA) with a Underperform and $6 target.
Topeka Capital assumes Monsanto (NYSE: MON) at Hold and price target of $83.
Maxim Group starts ImmunoCellular Therapeutics (NYSE: IMUC) at Buy and $18 target.
Rigel Pharmaceuticals (Nasdaq: RIGL) started by two today:
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Longbow Research lifts AK Steel (NYSE: AKS) from Neutral to Buy.
Piper Jaffray boosts Activision Blizzard (Nasdaq: ATVI) from Neutral to Overweight, moving its price target from $13 to $14.
JPMorgan upgrades Randgold Resources Ltd. (Nasdaq: GOLD) from Neutral to Overweight.
Janney Montgomery Scott raises Wright Express (NYSE: WXS) from Neutral to Buy, while moving its price target from $61 up to $75.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Nokia (NYSE: NOK) downgraded by two today:
- Societe Generale from Sell to Hold; and
- Deutsche Bank from Hold to Sell, while dropping its price target from €1.70 to €1.60. Click Here for more color.
- Longbow Research from Buy to Neutral; and
- UBS from Buy to Neutral.
- Needham & Company from Buy to Hold. Click Here for more color;
- Craig-Hallum from Buy to Hold, moving its price target from $4.50 to $5; and
- FBN Securities from Sector Perform to Underperform.
- Raymond James from Strong Buy to Market Perform; and
- Stifel Nicolaus from Buy to Hold.
NEW COVERAGE
Credit Suisse initiates Arena Pharma (Nasdaq: ARNA) with a Underperform and $6 target.
Topeka Capital assumes Monsanto (NYSE: MON) at Hold and price target of $83.
Maxim Group starts ImmunoCellular Therapeutics (NYSE: IMUC) at Buy and $18 target.
Rigel Pharmaceuticals (Nasdaq: RIGL) started by two today:
- Leerink Swann at Outperform and price target of $16. Click Here for more color; and
- Roth Capital at Buy and $15 target.
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIQ Global Intelligence Plc (NIQ) PT Raised to $21 at Needham
- Needham on Klarna (KLAR): 'Shares Back to the Penalty Box'
- Needham: 'we think that the event was positive for IMDX'
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Credit Suisse, Piper Jaffray, Stifel, Deutsche Bank, UBS, JPMorgan, Raymond James, Needham & Company, Roth Capital, Janney Montgomery Scott, Longbow Research, Maxim Group, Notable Analyst Rating ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share